Clinical trials in human medicines
Submitted by Anonymous (not verified) on 13 November 2023 - 10:00
Clinical trials in human medicines
Opinion/decision on a Paediatric investigation plan (PIP): Skyrizi,Risankizumab, decision type: , therapeutic area: , PIP number: P/0497/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 9:56
Opinion/decision on a Paediatric investigation plan (PIP): Skyrizi,Risankizumab, decision type: , therapeutic area: , PIP number: P/0497/2022
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Arthritis, Rheumatoid, Date of authorisation: 22/03/2017, Date of refusal: 25/04/2013, Revision: 28, Status: Authorised
Submitted by Anonymous (not verified) on 13 November 2023 - 9:56
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Arthritis, Rheumatoid, Date of authorisation: 22/03/2017, Date of refusal: 25/04/2013, Revision: 28, Status: Authorised
Opinion/decision on a Paediatric investigation plan (PIP): Odevixibat, decision type: , therapeutic area: , PIP number: P/0515/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 9:44
Opinion/decision on a Paediatric investigation plan (PIP): Odevixibat, decision type: , therapeutic area: , PIP number: P/0515/2022
Opinion/decision on a Paediatric investigation plan (PIP): Entospletinib, decision type: , therapeutic area: , PIP number: P/0518/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 9:37
Opinion/decision on a Paediatric investigation plan (PIP): Entospletinib, decision type: , therapeutic area: , PIP number: P/0518/2022
Opinion/decision on a Paediatric investigation plan (PIP): Xenleta,Lefamulin, decision type: , therapeutic area: , PIP number: P/0535/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 9:33
Opinion/decision on a Paediatric investigation plan (PIP): Xenleta,Lefamulin, decision type: , therapeutic area: , PIP number: P/0535/2022
Network Portfolio
Submitted by Anonymous (not verified) on 13 November 2023 - 9:26
Network Portfolio
Biosimilar medicines: Overview
Submitted by Anonymous (not verified) on 13 November 2023 - 9:08
Biosimilar medicines: Overview
Biosimilars in the EU - Information guide for healthcare professionals
Submitted by Anonymous (not verified) on 13 November 2023 - 9:07
Biosimilars in the EU - Information guide for healthcare professionals
Opinion/decision on a Paediatric investigation plan (PIP): Sirturo,bedaquiline fumarate, decision type: , therapeutic area: , PIP number: P/0470/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 8:58
Opinion/decision on a Paediatric investigation plan (PIP): Sirturo,bedaquiline fumarate, decision type: , therapeutic area: , PIP number: P/0470/2022